logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

逆市大涨!生物技术公司格劳科斯股价飙升近14%

Virus Panic Again? Biotech Stocks Rise on Hantavirus News

May 12, 2026

Life Science

Hantavirus Fears Fuel Moderna Rally: Is This a Real Catalyst or Just Sentiment?

Hantavirus Fears Fuel Moderna Rally: Is This a Real Catalyst or Just Sentiment?

May 11, 2026

Life Science

When Washington Turns Off The Cloud

May 11, 2026

Life Science

Is Pfizer’s 6.5% Dividend a Yield Trap? Q1 Results Put Speculation to Rest

Is Pfizer’s 6.5% Dividend a Yield Trap? Q1 Results Put Speculation to Rest

May 7, 2026

Life Science

逆向投资良机:这两支生物科技股当前被严重低估

Three Under-the-Radar Biotech Stocks to Watch in 2026

May 5, 2026

Life Science

Palantir PLTR beats Q1, lifts outlook. Why is stock down?

May 5, 2026

Life Science

Eli Lilly’s Alzheimer’s Drug Kisunla Wins Health Canada Approval, Bolstering Global Footprint

Eli Lilly’s Alzheimer’s Drug Kisunla Wins Health Canada Approval, Bolstering Global Footprint

May 4, 2026

Life Science

GLP-1s and AI Are the Big Themes Behind These 5 Top-Rated Health Care Picks for 2026

GLP-1s and AI Are the Big Themes Behind These 5 Top-Rated Health Care Picks for 2026

May 4, 2026

Life Science

AI驱动未来医疗,BioNTech股价应声上涨近4%

Want to Build Real Wealth in the Healthcare Sector? These Stocks Are Worth Considering

Apr 30, 2026

Life Science

Pfizer’s 6.7% Dividend: Can It Survive Plunging Profits and Cash Flow Crunch?

Bristol Myers Squibb Beats on Q1 Sales, Profit; Stock Jumps 5% as Growth Portfolio Shines

Apr 30, 2026

Life Science

Shorted-to-the-hilt KalVista rockets 39% as Chiesi swoops in with $1.9bn cash bid

Shorted-to-The-Hilt KalVista Rockets 39% as Chiesi Swoops in With $1.9bn Cash Bid

Apr 29, 2026

Life Science

High-Yield Healthcare Plays: MPT and Pfizer Offer 7% and 6.4% Dividends as Markets Turn Choppy

High-Yield Healthcare Plays: MPT and Pfizer Offer 7% and 6.4% Dividends as Markets Turn Choppy

Apr 28, 2026

Life Science, Real Estate

Organon Shares Extend Rally as India’s Sun Pharma Strikes $11.75 Billion All-Cash Deal

Organon Shares Extend Rally as India’s Sun Pharma Strikes $11.75 Billion All-Cash Deal

Apr 27, 2026

Life Science

Why Moderna and Regeneron Look Like Long-Term Bargains Amid the Selloff

Why Moderna and Regeneron Look Like Long-Term Bargains Amid the Selloff

Apr 21, 2026

Life Science

Trump Orders Fast-Track for Psychedelic Therapies—Who Stands to Win the Most?

Trump Orders Fast-Track for Psychedelic Therapies—Who Stands to Win the Most?

Apr 20, 2026

Life Science

Organon Shares Extend Rally as India’s Sun Pharma Strikes $11.75 Billion All-Cash Deal

Lilly in Advanced Talks to Acquire Kelonia for Over $2 Billion—Is a 39x P/E Still Too Rich?

Apr 19, 2026

Life Science

Kone Nears TK Elevator Deal at EUR 25B; OTIS in Focus

Apr 17, 2026

Life Science

押注未来:瞄准2026年高增长潜力的两家生物科技公司

Low-Key but Strong, Three Overlooked Biotech Stocks Worth Watching

Apr 16, 2026

Life Science

  • ‹‹ Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada